Trial intelligence / Profile preview

Asoprisnil in Treatment-Resistant Menorrhagia

NCT00288691Phase 2Completed

Sponsor
Bayer
Start
Nov 2001
Modality
Small Molecules
01

Overview

A Phase 2 trial of asoprisnil in Menorrhagia, sponsored by Bayer. Started Nov 2001; status: completed.

02

Drugs

asoprisnil
03

Conditions

Menorrhagia

Beyond the preview

Go deeper on NCT00288691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00288691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call